Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

7:55 AM ET 8-K
M&A Deal Lindblad Expeditions Holdings, Inc. LIND

Lindblad Expeditions Holdings Signs $61M M&A Deal with White Desert Ltd, PNR Airways Ltd and Echo Charlie Ltd

Lindblad Expeditions acquired a 60% controlling interest in White Desert and Echo Charlie, pioneers in Antarctic interior expeditions and aviation-based experiential travel, for approximately $61 million in cash. The deal includes options for Lindblad to acquire the remaining 40% in 2030 and 2031 and marks the largest transaction in the company's history, significantly expanding its polar exploration portfolio.

Value
$61M
Counterparty
White Desert Ltd, PNR Airways Ltd and Echo Charlie Ltd
7:30 AM ET 8-K
Clinical Trial Data BlossomHill Therapeutics, Inc. BLSM

BlossomHill Therapeutics Clinical Trial Data

BlossomHill Therapeutics announced updated Phase 1/2 SOLARA trial data for BH-30643 in patients with EGFR C797S-positive NSCLC, showing a 45% objective response rate and 88% disease control rate. The results, presented at the 2026 World Conference on Lung Cancer, demonstrate the drug's potential to overcome resistance to existing EGFR inhibitors in a population with no approved targeted therapies. The company plans to advance the candidate into a Phase 2 trial in 2027 following its recent FDA Fast Track designation.

Counterparty
International Association for the Study of Lung Cancer (IASLC)
7:15 AM ET 8-K
Capital Raise FibroBiologics, Inc. FBLG

FibroBiologics Capital Raise of $500K

FibroBiologics entered into a securities purchase agreement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for a private placement of 298,508 shares and equal warrants. The offering is expected to raise approximately $0.5 million in gross proceeds for general corporate purposes and working capital. The securities were priced at $1.675 per unit, representing the previous day's closing bid price plus a warrant premium.

Value
$500K
Counterparty
Hamid Khoja, Ph.D.
7:07 AM ET 8-K
Clinical Trial Data Connect Biopharma Holdings Ltd CNTB

Connect Biopharma Holdings Clinical Trial Data

Connect Biopharma announced positive topline results from its global Phase 2 study of rademikibart as an add-on treatment for acute asthma exacerbations. The study met its key secondary endpoint with a statistically significant improvement in lung function (FEV1) at Day 7, and while the primary endpoint of treatment failure reduction (66%) did not reach statistical significance due to lower-than-projected event rates, the company plans to engage with the FDA for a Phase 3 program.

Earnings call
Sep 15, 2026, 8:00 AM ET
7:01 AM ET 8-K
Divestiture Truist Financial Corp TFC

Truist Financial Divestiture for $5.5B

Truist Financial Corporation entered into an agreement to sell $5.5 billion of auto loans, representing substantially all assets of its Regional Acceptance Corporation (RAC) subsidiary. The transaction is part of a strategic exit from the near-prime auto lending business and is expected to generate $5.2 billion in net proceeds and $945 million in CET1 capital.

Value
$5.5B
6:46 AM ET 8-K
Clinical Trial Data Vera Therapeutics, Inc. VERA

Vera Therapeutics Clinical Trial Data

Vera Therapeutics announced positive topline results from the final efficacy analysis of its Phase 3 ORIGIN 3 trial of TRUTAKNA (atacicept-vymj) in patients with IgA nephropathy. The trial met all prespecified endpoints, demonstrating a 76% reduction in the risk of kidney disease progression and stabilization of kidney function (eGFR) through 104 weeks. The company plans to submit a supplemental BLA for full FDA approval in the fourth quarter of 2026.

Term
104 weeks
6:44 AM ET 8-K
M&A Deal Rocket Lab Corp RKLB

Rocket Lab Signs $1.94B M&A Deal with Iridium Communications Inc.

Rocket Lab provided a status and financing update on its pending acquisition of Iridium Communications, announcing the deal is now fully funded. The company completed a $1.944 billion ATM equity offering and amended Iridium's existing $1.775 billion credit facility to permit the change of control, allowing Rocket Lab to terminate a previous $3.6 billion bridge facility.

Value
$1.94B
Counterparty
Iridium Communications Inc.
6:17 AM ET 8-K
Contract Win Transocean Ltd. RIG

Transocean Wins $80M Contract from undisclosed operator

Transocean's ultra-deepwater drillship, Deepwater Conqueror, was awarded a two-well contract for work in Equatorial Guinea. The 170-day campaign is expected to begin in 2027 and will contribute approximately $80 million in backlog, excluding mobilization and demobilization fees.

Value
$80M
Counterparty
undisclosed operator
Term
170 days
6:14 AM ET 8-K
M&A Deal Hubilu Venture Corp HBUV

Hubilu Venture Signs $600K M&A Deal with Finance of America Reverse LLC

Hubilu Venture Corporation, through its subsidiary Elata Investments, LLC, completed the acquisition of a real property asset located at 5717 4th Ave in Los Angeles for $600,000. The acquisition was financed in part by a $550,000 first position note from Orchard Funding bearing interest at 9.99% per annum.

Value
$600K
Counterparty
Finance of America Reverse LLC
6:07 AM ET 8-K
M&A Deal Iridium Communications Inc. IRDM

Iridium Communications M&A Deal with Rocket Lab Corporation

Iridium Communications entered into a fourth amendment to its credit agreement to facilitate its pending merger with Rocket Lab Corporation. The amendment ensures the transaction does not trigger a 'Change of Control' default and secures lender consent for the merger, while adjusting interest rates and adding a downstream guarantee from Rocket Lab USA, Inc. upon closing.

Counterparty
Rocket Lab Corporation
6:07 AM ET 8-K
M&A Deal Atkore Inc. ATKR

Atkore M&A Deal with Prysmian S.p.A.

Atkore Inc. announced the expiration of the HSR Act waiting period regarding its pending acquisition by Prysmian S.p.A. The expiration of the antitrust waiting period satisfies a key closing condition for the merger, which remains subject to stockholder approval and other customary conditions.

Counterparty
Prysmian S.p.A.
6:07 AM ET 8-K
Nasdaq/NYSE Compliance Notice Profusa, Inc. PFSA

Profusa Nasdaq/NYSE Compliance Notice

Profusa, Inc. received a letter from Nasdaq confirming it has regained compliance with the minimum bid price and stockholders' equity requirements. As a result, the company will be subject to a one-year Mandatory Panel Monitor period, during which any further non-compliance with the equity rule will result in a prompt delisting determination without a cure period. The company intends to continue monitoring its status to maintain its listing on The Nasdaq Capital Market.

Counterparty
The Nasdaq Stock Market LLC
Term
1 year
6:07 AM ET 8-K
Nasdaq/NYSE Compliance Notice Innsuites Hospitality Trust IHT

Innsuites Hospitality Trust Nasdaq/NYSE Compliance Notice

InnSuites Hospitality Trust received notice that NYSE American has accepted its compliance plan, granting an extension through December 24, 2027, to regain compliance with continued listing standards. The Trust recently increased stockholders' equity by $3 million and is exploring strategic alternatives, including a potential reverse merger, to meet the exchange's requirements.

Counterparty
NYSE American
Term
through Dec 24, 2027
6:04 AM ET 8-K
Capital Raise Tyra Biosciences, Inc. TYRA

Tyra Biosciences Capital Raise of $400M

Tyra Biosciences entered into an underwriting agreement to raise approximately $400 million through the sale of 9,079,000 shares of common stock and 9,078,529 pre-funded warrants. The offering was led by RA Capital Management and includes participation from several institutional investors to fund the development of dabogratinib and other pipeline programs. The common stock is priced at $22.03 per share, with the offering expected to close on September 15, 2026.

Value
$400M
Counterparty
Jefferies LLC
5:27 PM ET 8-K/A
M&A Deal House of Doge Inc. HODO

House of Doge M&A Deal with House of Doge Inc.

House of Doge Inc. (formerly Brag House Holdings, Inc.) completed its merger with House of Doge Inc. (Texas), which now survives as a wholly-owned subsidiary. The transaction was structured as a reverse recapitalization where the Texas-based House of Doge is the accounting acquirer, and the company has rebranded and changed its ticker to 'HODO' on the Nasdaq.

Counterparty
House of Doge Inc. (Texas corporation)
5:26 PM ET 8-K
M&A Deal DevvStream Corp. DEVSF

DevvStream M&A Deal with XCF Global, Inc. and Southern Energy Renewables Inc.

DevvStream Corp. entered into an amendment to its existing business combination agreement with XCF Global and Southern Energy Renewables. The amendment modifies the pro forma ownership structure, increasing DevvStream shareholders' post-merger stake to approximately 10.43% while reducing Southern Energy's stake to approximately 20%.

Counterparty
XCF Global, Inc. and Southern Energy Renewables Inc.
5:03 PM ET 8-K
M&A Deal Nextera Energy Inc NEE

Nextera Energy M&A Deal with Dominion Energy, Inc.

NextEra Energy and Dominion Energy announced an enhanced Virginia benefits package to support their pending merger, including four years of residential bill credits and $100 million in low-income assistance. The update also commits to creating 1,000 new jobs in Virginia and building a new shareholder-funded co-headquarters tower in Richmond to address stakeholder feedback and regulatory priorities.

Counterparty
Dominion Energy, Inc.
5:03 PM ET 8-K
M&A Deal Z Squared Inc. ZSQR

Z Squared Signs $5M M&A Deal with Paradox Data, LLC

Z Squared Inc. completed the acquisition of 100% of Paradox Data, LLC from Paradox Infrastructure LLC for $5 million in Series A Convertible Preferred Stock. The acquisition includes the Union County Campus in Arkansas, an energized data center site with 8.0 MW of existing power capacity and a development target of 150+ MW for AI infrastructure.

Value
$5M
Counterparty
Paradox Data, LLC

“In August we told our shareholders to judge us on four things: whether the Paradox acquisition closes, whether we sign our first paying tenant and megawatt commitments, whether energized capacity at Union County grows beyond the current 8 megawatts, and whether we add sites without taking on debt. We have met our first goal. We closed, we paid in stock, and we took on no debt to do it.”

David Halabu, Chief Executive Officer of Z Squared
4:48 PM ET 8-K
M&A Deal BIO-TECHNE Corp TECH

BIO-TECHNE M&A Deal with Merck KGaA, Darmstadt, Germany

Bio-Techne Corporation provided a status update on its pending merger with Merck KGaA, Darmstadt, Germany, specifically addressing shareholder litigation and demand letters alleging disclosure deficiencies in the proxy statement. To avoid potential delays to the merger and the scheduled September 23, 2026 shareholder vote, the company has voluntarily issued supplemental disclosures while maintaining that the legal claims are without merit.

Counterparty
Merck KGaA, Darmstadt, Germany
4:44 PM ET 8-K
M&A Deal Payoneer Global Inc. PAYO

Payoneer Global M&A Deal with Nuvei

Payoneer Global Inc. stockholders approved the company's acquisition by Nuvei (Neon Maple Parent Inc.) at a special meeting held on September 14, 2026. Under the terms of the merger agreement, Payoneer will become a wholly owned subsidiary of Nuvei. Stockholders also approved the merger-related executive compensation on a non-binding, advisory basis.

Counterparty
Nuvei (Neon Maple Parent Inc.)
4:36 PM ET 8-K
Capital Raise Elmet Group Co. ELMT

Elmet Group Capital Raise of $450M

The Elmet Group received a $450 million committed investment from the U.S. Department of War's Economic Defense Unit to accelerate domestic tungsten manufacturing and secure critical mineral supply chains. The funding will support over $165 million in facility expansions across Maine, Michigan, and Ohio, as well as global mining operations in Australia and Spain. Additionally, the company secured a separate agreement worth up to $2 billion to support the National Defense Stockpile.

Value
$450M
Counterparty
United States Department of War
Earnings call
Aug 30, 2033, 9:00 AM ET

“This investment represents an important step toward securing a resilient supply of tungsten, a material that is critical to America’s defense, industrial, and economic future. The Elmet Group’s vertically integrated production capabilities, sourcing strategy, and commitment to expanding capacity positions our company to play a meaningful role in strengthening supply chains.”

Peter V. Anania, The Elmet Group CEO and Chairman
4:35 PM ET 8-K
M&A Deal Dominion Energy, Inc D

Dominion Energy M&A Deal with NextEra Energy, Inc.

Dominion Energy and NextEra Energy announced an enhanced Virginia benefits package related to their proposed merger, including doubling residential bill credits to four years and expanding low-income assistance by $100 million. The package also commits to creating 1,000 new jobs, building a new co-headquarters tower in Richmond, and establishing a $1 billion annual Virginia Supplier Program to support the local supply chain.

Counterparty
NextEra Energy, Inc.
4:35 PM ET 8-K
M&A Deal Drugs Made In America Acquisition Corp. DMAA

Drugs Made In America Acquisition M&A Deal Update

Drugs Made In America Acquisition Corp., a Special Purpose Acquisition Company (SPAC), has entered into a material definitive agreement, which typically signifies a definitive merger agreement or business combination with a target company. As a SPAC, this filing represents a major strategic milestone toward completing its initial business combination.

4:26 PM ET 8-K
M&A Deal Sysco Corp SYY

Sysco M&A Deal with Jetro Restaurant Depot

Sysco Corporation filed audited and pro forma financial statements related to its previously announced merger agreement with Jetro Restaurant Depot (JRD Unico Inc. and Warehouse Realty, LLC). The filing serves as a status and regulatory update to facilitate the incorporation of the target company's financial data into Sysco's registration statements as the acquisition progresses.

Counterparty
Jetro Restaurant Depot
4:17 PM ET 8-K
M&A Deal XCF Global, Inc. SAFX

XCF Global M&A Deal with DevvStream Corp. and Southern Energy Renewables Inc.

XCF Global entered into an amendment to its existing business combination agreement with DevvStream Corp. and Southern Energy Renewables. The amendment adjusts the pro forma ownership percentages, resulting in Southern Energy shareholders holding 20% and DevvStream shareholders holding 10.43% of the combined company upon closing.

Counterparty
DevvStream Corp. and Southern Energy Renewables Inc.
4:15 PM ET 8-K
M&A Deal Enova International, Inc. ENVA

Enova International M&A Deal with Grasshopper Bancorp, Inc.

Enova International has withdrawn its regulatory applications with the OCC and Federal Reserve for the proposed acquisition of Grasshopper Bancorp, Inc. The company cited a lack of clear regulatory standards for nonbanks and stated its future growth does not depend on becoming a bank. Enova reaffirmed its 2026 financial guidance and announced plans to accelerate share repurchases for the remainder of the year.

Counterparty
Grasshopper Bancorp, Inc.
Earnings call
Jun 30, 2027, 5:00 PM ET
4:14 PM ET 8-K
Nasdaq/NYSE Compliance Notice Longeveron Inc. LGVN

Longeveron Nasdaq/NYSE Compliance Notice

Longeveron Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its Class A common stock maintained a closing price of at least $1.00 for 10 consecutive business days. The company had previously been under a deficiency notice since September 2025 and was granted two 180-day extension periods to resolve the issue. Nasdaq has officially closed the matter, securing the company's continued listing on The Nasdaq Capital Market.

Counterparty
Nasdaq
4:11 PM ET 8-K
Capital Raise PDS Biotechnology Corp PDSB

PDS Biotechnology Capital Raise of $11.3M

PDS Biotechnology completed the initial closing of a PIPE financing led by Nant Capital, raising $11.3 million in gross proceeds through the sale of common stock and warrants. The company also announced a contingent milestone closing for an additional $11 million and appointed Dr. Patrick Soon-Shiong and James Banaag to its Board of Directors. Proceeds will be used to repay $4.6 million in debt to Yorkville and advance the PDS0301 clinical program.

Value
$11.3M
Counterparty
Nant Capital, LLC
4:11 PM ET 8-K
M&A Deal Magnolia Oil & Gas Corp MGY

Magnolia Oil & Gas Signs $2.57B M&A Deal with WildFire Energy I LLC

Magnolia Oil & Gas Corporation completed its acquisition of WildFire Energy I LLC for $2.57 billion in cash and 32,203,000 shares of Class A common stock. As part of the transaction, Magnolia assumed $600 million in 7.500% Senior Notes due 2029 and merged the target entities into its operating subsidiary.

Value
$2.57B
Counterparty
WildFire Energy I LLC
4:08 PM ET 8-K
M&A Deal Veracyte, Inc. VCYT

Veracyte Signs $150M M&A Deal with Convergent Genomics Inc.

Veracyte completed the acquisition of Convergent Genomics, a genomic diagnostics company focused on bladder cancer, for $150 million in upfront cash plus up to $30 million in milestone-based payments. The deal adds the UroAmp urinary tumor DNA (utDNA) technology to Veracyte's urology portfolio, with a commercial launch expected in late 2028.

Value
$150M
Counterparty
Convergent Genomics Inc.

“UroAmp brings a differentiated urine-based platform that is especially well suited to non-muscle-invasive disease. Together with our Decipher Bladder and TrueMRD tests, this acquisition strengthens Veracyte’s ability to deliver complementary insights from urine, tissue, and blood to help guide care across the bladder cancer continuum.”

Marc Stapley, Veracyte’s chief executive officer

“We believe this combination can help accelerate the development of new tools that give physicians greater confidence in treatment and monitoring decisions and can ultimately improve care for people living with bladder cancer.”

Brian Slingerland, chief executive officer, Convergent Genomics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.